logo
Sichuan Exosome Innovation Biological Technology Co., Ltd
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
中文
العربية
हिन्दी
Türkçe
bahasa indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
中文
العربية
हिन्दी
Türkçe
bahasa indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Immune Cells
Created with Pixso.

Innovative Immune Cells Redefining Therapeutic Horizons

Innovative Immune Cells Redefining Therapeutic Horizons

Brand Name: xinmixue
Model Number: bag
MOQ: negotiable
Price: negotiable
Payment Terms: T/T,negotiable
Supply Ability: No upper limit
Detail Information
Place of Origin:
chengdu china
Certification:
ios9001
Storage Conditions:
2°C-8°C
Sterility:
Sterile
Unit Per Bag:
3 Billion
Purity:
≥ 95%
Product Type:
Cell Culture Products
Endotoxin Level:
< 1 EU/µg
Cell Type:
Immune Cells
Supply Ability:
No upper limit
Highlight:

Sterile Immune Cells

,

Innovative Immune Cells

,

Purity 95 Immune Cells

Product Description
Innovative Immune Cells Redefining Therapeutic Horizons
Product Specifications
Attribute Value
Storage Conditions 2°C-8°C
Sterility Sterile
Unit per bag 3 billion
Purity ≥ 95%
Product Type Cell Culture Products
Endotoxin Level < 1 EU/µg
Cell Type Immune Cells
Product Overview
Our advanced immune cell products combine NK, T, CIK, and tumor-killing immune cells, extracted non-invasively from donors or patients and cultured in state-of-the-art laboratories. These cells form a powerful defense system specifically targeting cancer cells and disease-causing pathogens.
Innovative Immune Cells Redefining Therapeutic Horizons 0
Key Features
  • Multifunctional synergy: Different immune cells work in concert - NK cells initiate attacks, T cells provide targeted immunity, CIK cells enhance responses, and tumor-killing cells directly eliminate cancer cells for maximum therapeutic effect.
  • Gene-editing technology: We utilize CRISPR-Cas9 to enhance immune cell capabilities, including modifying T cells with CARs for improved cancer targeting precision.
  • Sustainable production: Our patented cell production system ensures a consistent supply of high-quality immune cells to meet growing clinical demand.
Technical Parameters
  • Cell viability: Maintained at 99% after rigorous quality control, ensuring optimal cell condition for therapeutic applications.
  • Cell purity: Purified to over 97% to eliminate contaminants and guarantee treatment safety and effectiveness.
  • Enhanced cytokine production: Our optimized culture conditions increase cytokine production by 50% compared to traditional methods, significantly boosting therapeutic effectiveness.
Clinical Applications
  • Refractory cancer treatment: Provides new hope for patients unresponsive to conventional cancer therapies, often used in combination with other treatment modalities.
  • Infectious disease control: Effective in preventing and treating infections, particularly those caused by drug-resistant pathogens such as in HIV patients.
  • Neurodegenerative disease research: Currently under investigation for potential applications in treating Alzheimer's and Parkinson's diseases through modulation of brain immune responses.